Siyuan Feng

Siyuan Feng

Auto-generated profile, based on publicly available information

Siyuan Feng

Northwestern University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
YGYazmin I. Rovira Gonzalez
Yazmin I. Rovira Gonzalez
AMAdam L. Moyer
Adam L. Moyer
NLNicolas J. LeTexier
Nicolas J. LeTexier
ABAugust D. Bratti
August D. Bratti
SFSiyuan Feng
Siyuan Feng
KWKathryn R. Wagner
Kathryn R. Wagner
Myostatin is a negative regulator of muscle growth and metabolism and its inhibition in mice improves insulin sensitivity, increases glucose uptake into skeletal muscle, and decreases total body fat. A recently described mammalian protein called MSS51 is significantly downregulated with myostatin inhibition. In vitro disruption of Mss51 results in increased levels of ATP, β-oxidation, glycolysis, and oxidative phosphorylation. To determine the in vivo biological function of Mss51 in mice, we disrupted the Mss51 gene by CRISPR/Cas9 and found that Mss51-KO mice have normal muscle weights and fiber-type distribution but reduced fat pads. Myofibers isolated from Mss51-KO mice showed an increased oxygen consumption rate compared with WT controls, indicating an accelerated rate of skeletal muscle metabolism. The expression of genes related to oxidative phosphorylation and fatty acid β-oxidation were enhanced in skeletal muscle of Mss51-KO mice compared with that of WT mice. We found that mice lacking Mss51 and challenged with a high-fat diet were resistant to diet-induced weight gain, had increased whole-body glucose turnover and glycolysis rate, and increased systemic insulin sensitivity and fatty acid β-oxidation. These findings demonstrate that MSS51 modulates skeletal muscle mitochondrial respiration and regulates whole-body glucose and fatty acid metabolism, making it a potential target for obesity and diabetes.

20 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
BWBrenda M. Wang
Brenda M. Wang
NCNicole Chiang
Nicole Chiang
HEHolly M. Ekas
Holly M. Ekas
DBDylan M. Brown
Dylan M. Brown
GDGarrett Dildine
Garrett Dildine
MJMichael C. Jewett
Michael C. Jewett
Point-of-use diagnostics based on allosteric transcription factors (aTFs) are promising tools for environmental monitoring and human health. However, biosensors relying on natural aTFs rarely exhibit the sensitivity and selectivity needed for real-world applications, and traditional directed evolution struggles to optimize multiple biosensor properties at once. To overcome these challenges, we develop a multi-objective, machine learning (ML)-guided cell-free gene expression workflow for engineering aTF-based biosensors. Our approach rapidly generates high-quality sequence-to-function data, which we transform into an augmented paired dataset to train an ML model using directional labels that capture how aTF mutations alter performance. We apply our workflow to engineer the aTF PbrR as a point-of-use diagnostic for lead contamination in water. We tune the sensitivity of PbrR to sense at the U.S. Environmental Protection Agency (EPA) action level for lead and modify the selectivity away from zinc, a common metal found in water supplies. Finally, we show that the engineered PbrR functions in freeze-dried cell-free reactions, enabling a diagnostic capable of detecting lead in drinking water down to ~5.7 ppb. Our ML-driven, multi-objective framework powered by directional tokens can generalize to other biosensors and proteins, accelerating the development of synthetic biology tools for biotechnology applications.

10 February 2026 in Current Opinion in Biotechnology
Verified
Journal Article
Open access
AAAnibal Arce
Anibal Arce
DBDylan M Brown
Dylan M Brown
HDHerma A Demissie
Herma A Demissie
SFSiyuan Feng
Siyuan Feng
MNMaram Naji
Maram Naji
JLJulius B Lucks
Julius B Lucks
Cell-free biosensors have the potential to become a low-cost, widely distributed technology. If deployed at scale, they can generate new large-scale data streams about human health and our environment, providing actionable information at the point of need. Here, we review the key technological advances of cell-free biosensors over the last five years and suggest a future path of technology development, including interfacing with circuits, devices, and materials that are becoming part of the next generation of biosensors. We then ask what is needed for these technologies to succeed at scale, focusing on lessons from field-deployment studies, policy, regulatory, safety, and other considerations to ensure alignment of technological developments with real-world necessities, market opportunities, and reliable use by non-experts.

3 July 2026 in bioRxiv
Verified
Preprint
Open access
SFSiyuan Feng
Siyuan Feng
RRRebecca Rasmussen
Rebecca Rasmussen
AGAntonio Garcia
Antonio Garcia
LCLauren Clark
Lauren Clark
SSSamanvaya Srivastava
Samanvaya Srivastava
JLJulius B Lucks
Julius B Lucks
Cell-free biosensors leverage in vitro gene expression reactions to detect chemicals. While inexpensive, modular, and distributable, these platforms are constrained by slow readouts at ambient temperatures, precluding practical field operation. In cells, phase separation accelerates biochemical reactions; however, recapitulating these gains in vitro has remained challenging for complex biochemistries. Here, we report the first self-assembling coacervate system that accelerates in vitro transcription. Prepared by simple mixing, coacervation with spermine and polyacrylic acid occurs dynamically in response to NTP consumption and co-localizes DNA templates and RNA polymerase to accelerate transcription, mimicking intracellular phenomena. We exploit this discovery to accelerate the cell-free biosensing of six ligands, demonstrating that coacervation can preserve platform modularity, improve sensitivity, retain lyophilization compatibility, function in field matrices, and reduce ambient-temperature time-to-signal by hours. This work contributes to a growing understanding of phase separation in biology and advances the use of membrane-less organization for real-world applications.